Ignite Creation Date:
2025-12-24 @ 7:31 PM
Ignite Modification Date:
2026-03-06 @ 8:46 AM
Study NCT ID:
NCT02656303
Status:
TERMINATED
Last Update Posted:
2023-06-22
First Post:
2016-01-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety and Efficacy of Ublituximab in Combination With Umbralisib for Participants Previously Enrolled in Protocol UTX-TGR-304
Sponsor:
TG Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01-07
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-11
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-13
First Submit QC Date:
None
Study First Post Date:
2016-01-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-05-26
Results First Submit QC Date:
None
Results First Post Date:
2023-06-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-26
Last Update Post Date:
2023-06-22
Last Update Post Date Type:
ACTUAL